Dexcom (DXCM): Valuation Check After Launch of Dexcom Academy for EMEA Healthcare Professionals

Simply Wall St.12-18 17:24

DexCom (DXCM) just rolled out Dexcom Academy, a personalised learning platform for healthcare professionals across several EMEA markets, aiming to deepen CGM expertise and quietly reinforce demand for...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2592974515?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","is_english":true,"pubTime":"2025-12-18 17:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2592974515","market":"nz","top_or_hot":-1,"title":"Dexcom (DXCM): Valuation Check After Launch of Dexcom Academy for EMEA Healthcare Professionals","media":"Simply Wall St.","content":"<div>\n<p>DexCom (DXCM) just rolled out Dexcom Academy, a personalised learning platform for healthcare professionals across several EMEA markets, aiming to deepen CGM expertise and quietly reinforce demand for...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-dxcm/dexcom/news/dexcom-dxcm-valuation-check-after-launch-of-dexcom-academy-f\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dexcom (DXCM): Valuation Check After Launch of Dexcom Academy for EMEA Healthcare Professionals</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDexcom (DXCM): Valuation Check After Launch of Dexcom Academy for EMEA Healthcare Professionals\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-18 17:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-dxcm/dexcom/news/dexcom-dxcm-valuation-check-after-launch-of-dexcom-academy-f><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DexCom (DXCM) just rolled out Dexcom Academy, a personalised learning platform for healthcare professionals across several EMEA markets, aiming to deepen CGM expertise and quietly reinforce demand for...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-dxcm/dexcom/news/dexcom-dxcm-valuation-check-after-launch-of-dexcom-academy-f\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2211815571.USD","symbol_name":"ALLIANZ POSITIVE CHANGE \"AT\" (USD) ACC","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-dxcm/dexcom/news/dexcom-dxcm-valuation-check-after-launch-of-dexcom-academy-f","article_id":"2592974515","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-dxcm/dexcom/news/dexcom-dxcm-valuation-check-after-launch-of-dexcom-academy-f","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2592974515","pubTimestamp":1766049879,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"DexCom (DXCM) just rolled out Dexcom Academy, a personalised learning platform for healthcare professionals across several EMEA markets, aiming to deepen CGM expertise and quietly reinforce demand for its growing diabetes technology portfolio.\nSee our latest analysis for DexCom.\nThe launch of Dexcom Academy comes at a time when sentiment around DexCom is still resetting. A 30 day share price return of 12.41% has helped to partially offset a year to date share price decline of 16.24% and a...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2211815571.USD":"ALLIANZ POSITIVE CHANGE \"AT\" (USD) ACC","BK4082":"医疗保健设备","DXCM":"德康医疗","BK4504":"桥水持仓","XLV":"健康照护类股ETF-SPDR","XBI":"SPDR S&P Biotech ETF","LU0029874061.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","BK4588":"碎股","LU2433249047.HKD":"THEMATICS META \"R/A\" (HKD) ACC","BK4548":"巴美列捷福持仓","LU0354030511.USD":"ALLSPRING  U.S. LARGE CAP GROWTH \"I\" (USD) ACC","BK4551":"寇图资本持仓","LU0354030438.USD":"富国美国大盘成长基金Cl A Acc","BK4137":"综合支持服务","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","BK4581":"高盛持仓","IE00BMPRXR70.SGD":"Neuberger Berman 5G Connectivity A Acc SGD-H","IE00BMPRXN33.USD":"NEUBERGER BERMAN 5G CONNECTIVITY \"A\" (USD) ACC","LABU":"三倍做多标普生物-Direxion","LU0128526141.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC","LU2125909247.SGD":"Natixis Thematics Meta H-R/A SGD","LU1923622614.USD":"Natixis Thematics Meta R/A USD","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","LU1323610961.USD":"UBS (LUX) EQUITY SICAV - LONG TERM THEMES (USD) \"P\" (USD) ACC","LU2125909593.SGD":"Natixis Thematics Meta R/A SGD","HCSG":"Healthcare Svcs Group Inc"},"translate_title":"Dexcom(DXCM)：为EMEA医疗保健专业人员推出Dexcom学院后的估值检查","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XBI":0.6,"HCSG":1.5,"XLV":1.5,"DXCM":1.5,"LABU":0.6},"content_text":"DexCom (DXCM) just rolled out Dexcom Academy, a personalised learning platform for healthcare professionals across several EMEA markets, aiming to deepen CGM expertise and quietly reinforce demand for its growing diabetes technology portfolio. See our latest analysis for DexCom. The launch of Dexcom Academy comes at a time when sentiment around DexCom is still resetting. A 30 day share price return of 12.41% has helped to partially offset a year to date share price decline of 16.24% and a more challenging multi year total shareholder return. If this kind of targeted product rollout interests you, it could be worth exploring other innovative healthcare names using our screener for healthcare stocks. Against that backdrop, markets still value DexCom below analyst targets even as revenue and profit climb. This raises a central question for investors: is this a mispriced growth story, or is the market already discounting its next leg of expansion? Most Popular Narrative: 22.5% Undervalued With DexCom closing at $65.75 versus a most popular narrative fair value of $84.85, the story frames today’s price as a sizable discount to its long term earnings power.  Analysts are assuming DexCom's revenue will grow by 14.8% annually over the next 3 years. Analysts assume that profit margins will increase from 13.3% today to 21.9% in 3 years time.  Read the complete narrative. Want to see what turns those growth and margin ambitions into a higher fair value? The narrative focuses on bold earnings expansion and a richer future multiple. Curious which assumptions really carry the valuation? Explore the full roadmap behind that price. Result: Fair Value of $84.85 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, emerging legal and safety scrutiny around G7, along with potential Medicare pricing pressure from competitive bidding, could quickly challenge this upbeat valuation roadmap. Find out about the key risks to this DexCom narrative.  Build Your Own DexCom Narrative If you are not fully convinced by this storyline or prefer to dig into the numbers yourself, you can build a personalised view in just minutes: Do it your way. A good starting point is our analysis highlighting 4 key rewards investors are optimistic about regarding DexCom. Looking for more investment ideas? Before you move on, lock in your next potential winner by using the Simply Wall St Screener to uncover opportunities that others may be overlooking right now.  Capitalize on mispriced opportunities by targeting these 910 undervalued stocks based on cash flows that the market may be sleeping on. Ride powerful digital trends by focusing on these 80 cryptocurrency and blockchain stocks that could reshape how money and transactions work. Boost your income potential with these 13 dividend stocks with yields > 3% offering attractive yields above 3% while you wait for growth.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.Mobile Infrastructure for Defense and DisasterThe next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.Get the investor briefing before the next round of contractsSponsored On Behalf of CiTechNew: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2592974515","isCrawlerRequest":true}